Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion.

Wolfram syndrome, an autosomal recessive disorder characterized by juvenile-onset diabetes mellitus and optic atrophy, is caused by mutations in the WFS1 gene. In order to gain insight into the pathophysiology of this disease, we disrupted the wfs1 gene in mice. The mutant mice developed glucose intolerance or overt diabetes due to insufficient insulin secretion in vivo. Islets isolated from mutant mice exhibited a decrease in insulin secretion in response to glucose. The defective insulin secretion was accompanied by reduced cellular calcium responses to the secretagogue. Immunohistochemical analyses with morphometry and measurement of whole-pancreas insulin content demonstrated progressive beta-cell loss in mutant mice, while the alpha-cell, which barely expresses WFS1 protein, was preserved. Furthermore, isolated islets from mutant mice exhibited increased apoptosis, as assessed by DNA fragment formation, at high concentration of glucose or with exposure to endoplasmic reticulum-stress inducers. These results strongly suggest that WFS1 protein plays an important role in both stimulus-secretion coupling for insulin exocytosis and maintenance of beta-cell mass, deterioration of which leads to impaired glucose homeostasis. These WFS1 mutant mice provide a valuable tool for understanding better the pathophysiology of Wolfram syndrome as well as WFS1 function.

[1]  M. Permutt,et al.  Wolframin Expression Induces Novel Ion Channel Activity in Endoplasmic Reticulum Membranes and Increases Intracellular Calcium* , 2003, Journal of Biological Chemistry.

[2]  C. Cremers,et al.  Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease , 2003, Human mutation.

[3]  K. Gerbitz,et al.  Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. , 2003, Human molecular genetics.

[4]  S. Reddy,et al.  Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes , 2003, Histochemistry and Cell Biology.

[5]  C. Kahn,et al.  Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. , 2003, Diabetes.

[6]  A. Desautels,et al.  Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  G. Lienhard,et al.  Impact of Genetic Background and Ablation of Insulin Receptor Substrate (IRS)-3 on IRS-2 Knock-out Mice* , 2003, The Journal of Biological Chemistry.

[8]  C. Wollheim,et al.  Islet β-cell secretion determines glucagon release from neighbouring α-cells , 2003, Nature Cell Biology.

[9]  Y. Oka,et al.  The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells , 2003, Histochemistry and Cell Biology.

[10]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[11]  D. Ron,et al.  Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.

[12]  R. Kaufman.  Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.

[13]  M. McCarthy,et al.  Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. , 2002, Diabetes.

[14]  H. Joller-jemelka,et al.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[15]  G. Kroemer,et al.  Organelle-specific initiation of cell death pathways , 2001, Nature Cell Biology.

[16]  S. Leal,et al.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. , 2001, Human molecular genetics.

[17]  M. King,et al.  Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1. , 2001, Human molecular genetics.

[18]  D. Ron,et al.  Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. , 2001, Molecular cell.

[19]  Yoshifumi Watanabe,et al.  WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. , 2001, Human molecular genetics.

[20]  Yoshifumi Watanabe,et al.  WFS 1 ( Wolfram syndrome 1 ) gene product : predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain , 2001 .

[21]  M. Swift,et al.  Psychiatric disorders and mutations at the Wolfram syndrome locus , 2000, Biological Psychiatry.

[22]  Y. Kanazawa,et al.  Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. , 2000, Biochemical and biophysical research communications.

[23]  E. Cerasi,et al.  Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.

[24]  T. Meitinger,et al.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. , 1998, Human molecular genetics.

[25]  P. Behn,et al.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.

[26]  K. Higashi,et al.  Evidence of an increased risk of hearing loss in heterozygous carriers in a Wolfram syndrome family , 1998, Human Genetics.

[27]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Miyazaki,et al.  Inhibition of pancreatic β‐cell glucokinase by antisense RNA expression in transgenic mice: mouse strain‐dependent alteration of glucose tolerance , 1995, FEBS letters.

[29]  J. Horton,et al.  Wolfram syndrome , 1992, Neurology.

[30]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[31]  J. Leahy,et al.  Islet Mass and Function in Diabetes and Transplantation , 1990, Diabetes.

[32]  A. Karasik,et al.  Genetically Programmed Selective Islet β-Cell Loss in Diabetic Subjects With Wolfram's Syndrome , 1989, Diabetes Care.

[33]  D. Coleman.  Diabetes-Obesity Syndromes in Mice , 1982, Diabetes.

[34]  H. P. Wagener,et al.  DIABETES MELLITUS AND SIMPLE OPTIC ATROPHY AMONG SIBLINGS: REPORT OF FOUR CASES , 1938 .